Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2917375 | 0.99 | LMNA (0.39) | LMNATDP1MEN1MAPTTHRB | |
| SCHEMBL1797109 | 0.99 | LMNA (0.39) | LMNATDP1MEN1MAPTTHRB | |
| SCHEMBL2064627 | 0.95 | LMNA (0.38) | LMNATDP1MEN1MAPTTHRB | |
| SCHEMBL3242091 | 0.91 | LMNA (0.30) | LMNATDP1 | |
| SCHEMBL12617278 | 0.91 | MEN1 (0.39) | LMNATDP1MEN1MAPTTHRB | |
| SCHEMBL13351848 | 0.91 | MEN1 (0.39) | LMNATDP1MEN1MAPTTHRB | |
| SCHEMBL1797108 | 0.90 | MEN1 (0.39) | LMNATDP1MEN1MAPTTHRB | |
| SCHEMBL3242102 | 0.90 | LMNA (0.31) | LMNATDP1 | |
| SCHEMBL137086 | 0.90 | LMNA (0.31) | LMNATDP1 | |
| SCHEMBL1797106 | 0.88 | LMNA (0.39) | LMNATDP1MEN1MAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951959-B2 | Hydrophilic labels for biomolecules | Thermo Fisher Scientific (Milwaukee) LLC (US) | 2011-05-31 | — | — | US | disclosed |
| US-7745640-B2 | Hydrophilic labels for biomolecules | DYOMICS GMBH (DE) | 2010-06-29 | — | — | US | disclosed |
| EP-2184326-A2 | Hydrophilic labels for biomolecules | Thermo Fischer (Milwaukee) LLC (US) | 2010-05-12 | — | — | EP | disclosed |
| US-20100069258-A1 | Hydrophilic Labels for Biomolecules | Thermo Fisher Scientific (Milwaukee) LLC (US) | 2010-03-18 | — | — | US | disclosed |
| US-20070128659-A1 | HYDROPHILIC LABELS FOR BIOMOLECULES | DYOMICS GMBH (DE) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069258-A1 | Hydrophilic Labels for Biomolecules | HIRA, ALB, SSB | LMNA 261/4885TDP1 1224/4885MEN1 2655/4885 |
| US-20070128659-A1 | HYDROPHILIC LABELS FOR BIOMOLECULES | DDB1, ALB, HIRA | LMNA 150/4885TDP1 1325/4885MEN1 2710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.